Biodesix (NASDAQ:BDSX – Get Free Report) and Agilon Health (NYSE:AGL – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, institutional ownership, valuation, profitability, analyst recommendations, earnings and dividends.
Earnings & Valuation
This table compares Biodesix and Agilon Health”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Biodesix | $88.50 million | 1.81 | -$35.26 million | ($4.06) | -3.81 |
| Agilon Health | $5.93 billion | 0.27 | -$391.35 million | ($21.56) | -4.47 |
Analyst Recommendations
This is a summary of recent ratings and recommmendations for Biodesix and Agilon Health, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Biodesix | 1 | 0 | 2 | 0 | 2.33 |
| Agilon Health | 2 | 8 | 5 | 0 | 2.20 |
Biodesix currently has a consensus target price of $22.00, indicating a potential upside of 42.30%. Agilon Health has a consensus target price of $58.73, indicating a potential downside of 39.07%. Given Biodesix’s stronger consensus rating and higher probable upside, equities research analysts plainly believe Biodesix is more favorable than Agilon Health.
Insider & Institutional Ownership
21.0% of Biodesix shares are held by institutional investors. 23.2% of Biodesix shares are held by company insiders. Comparatively, 2.3% of Agilon Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Volatility & Risk
Biodesix has a beta of 0.59, suggesting that its share price is 41% less volatile than the S&P 500. Comparatively, Agilon Health has a beta of 3.02, suggesting that its share price is 202% more volatile than the S&P 500.
Profitability
This table compares Biodesix and Agilon Health’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Biodesix | -33.26% | -2,101.40% | -35.65% |
| Agilon Health | -6.09% | -146.03% | -24.55% |
Summary
Biodesix beats Agilon Health on 8 of the 14 factors compared between the two stocks.
About Biodesix
Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR and NGS, and VeriStrat tests, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to establish the patient's prognosis and help guide treatment decisions. In addition, the company, through its partnership with Bio-Rad Laboratories, Inc., provides Bio-Rad SARS-CoV-2 ddPCR, a COVID-19 Test under Biodesix WorkSafe testing program; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. Further, it offers diagnostic and clinical research, as well as clinical trial testing services to biopharmaceutical companies; and discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.
About Agilon Health
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.
Receive News & Ratings for Biodesix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biodesix and related companies with MarketBeat.com's FREE daily email newsletter.
